Meridian Bioscience
VIVO
#5216
Rank
NZ$2.57 B
Marketcap
NZ$58.80
Share price
0.00%
Change (1 day)
26.28%
Change (1 year)

Meridian Bioscience (VIVO) - Total debt

Total debt on the balance sheet as of September 2022 : NZ$53.58 Million

According to Meridian Bioscience's latest financial reports the company's total debt is NZ$53.58 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Meridian Bioscience - Total debt on balance sheet (from 1996 to 2022)

Total debt by year

Year Total debt Change
2022-09-30NZ$54.91 M-42.54%
2021-09-30NZ$95.58 M-15.92%
2020-09-30NZ$0.11 B-6.11%
2019-09-30NZ$0.12 B59.82%
2018-09-30NZ$75.76 M-0.3%
2017-09-30NZ$75.98 M-5.47%
2016-09-30NZ$80.38 M
2006-09-30NZ$2.76 M-41.11%
2005-09-30NZ$4.69 M-82.29%
2004-09-30NZ$26.47 M-31.46%
2003-09-30NZ$38.63 M-33.89%
2002-09-30NZ$58.43 M-26.54%
2001-09-30NZ$79.54 M-7.76%
2000-09-30NZ$86.23 M67.8%
1999-09-30NZ$51.39 M23.54%
1998-09-30NZ$41.6 M27.96%
1997-09-30NZ$32.51 M-2.05%
1996-09-30NZ$33.19 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
QuidelOrtho
QDEL
NZ$4.92 B 9,086.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
NZ$61.76 B 115,156.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
NZ$33.47 B 62,376.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
NZ$4.36 B 8,048.40%๐Ÿ‡บ๐Ÿ‡ธ USA